Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05219825 · ClinicalTrials.gov registry record · NA
Breathwork-assisted Treatment for Cannabis Use Disorder
A NA study of Substance Abuse and Cannabis Use, sponsored by Elias Dakwar.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05219825: Active NA study of Substance Abuse and Cannabis Use, sponsored by Elias Dakwar.
NCT05219825 is a NA study of Substance Abuse and Cannabis Use that is active but no longer recruiting, run by Elias Dakwar. The registered enrollment target is 10 participants, below the 5,260-participant average among 58 other Substance Abuse trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05219825, a NA study of Substance Abuse and Cannabis Use, is active but no longer recruiting, sponsored by Elias Dakwar.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this proof-of-concept study is to evaluate the safety, feasibility and acceptability of a breathwork workshop intervention in individuals with cannabis use disorder.
Primary Outcome
Acceptability of the breathwork intervention through self-reported questionnaires.
Conditions Studied
Interventions
- BEHAVIORAL Breathwork workshop
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-02-06 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT05219825 still lists
NCT05219825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 5,260-participant average among 58 other Substance Abuse trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Breathwork workshop is the first listed.
NCT05219825 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05219825 about?
NCT05219825 is a clinical study titled "Breathwork-assisted Treatment for Cannabis Use Disorder". The purpose of this proof-of-concept study is to evaluate the safety, feasibility and acceptability of a breathwork workshop intervention in individuals with cannabis use disorder.
What is the current status of trial NCT05219825?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2022-02-06. Estimated completion is 2025-12-31.
What conditions does trial NCT05219825 study?
This clinical trial studies the following conditions: Substance Abuse, Cannabis Use, Cannabis Use Disorder, Addiction, Cannabis Dependence.
What interventions are being tested in trial NCT05219825?
The interventions under investigation include: Breathwork workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT05219825?
This trial is sponsored by Elias Dakwar, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05219825 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05219825's enrollment target sits among peer trials
10 59th of 58 the lowest of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI